首页> 美国卫生研究院文献>Indian Journal of Otolaryngology and Head Neck Surgery >Postural Control in Patients After a Recent Vestibular Neuritis with Hyperhomocysteinemia
【2h】

Postural Control in Patients After a Recent Vestibular Neuritis with Hyperhomocysteinemia

机译:最近的前庭神经炎合并高同型半胱氨酸血症的患者的姿势控制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To assess the possible role of hyperhomocysteinemia (HyHcy) in delaying recovery after acute vestibular neuritis. In our retrospective study, 90 subjects were evaluated within 7 days from the beginning of an acute vertigo. All subjects had high plasma levels of homocysteine (Hcy). 46 patients were treated with homocysteine lowering therapy and betahistine for 1 month, while 44 subjects received only betahistine. Subjective symptoms were evaluated with the Dizziness Handicap Inventory (DHI) questionnaire, administered 7 days after the beginning of vertigo and again after 1 month. Moreover, postural control performed at 1 month’ control was studied with static stabilometry in a subgroup of 21 non-treated and 20 treated patients. DHI total score decreased significantly more in the subgroup of subjects treated with homocysteine lowering therapy. Moreover, posturographic data were significantly increased in non-treated compared with treated subjects. Our data support the possibility of a role of HyHcy in preventing recovery after a recent vestibular neuritis. A microvascular disorder or the neurotoxic effect of HyHcy have been considered as possible causal factors. Although not conclusive, our data are not inconsistent with the hypothesis of a poorer adaptation in patients with untreated HyHcy.
机译:评估高同型半胱氨酸血症(HyHcy)在延迟急性前庭神经炎后恢复中的可能作用。在我们的回顾性研究中,从急性眩晕开始的7天内评估了90名受试者。所有受试者血浆中同型半胱氨酸(Hcy)含量较高。 46例患者接受了同型半胱氨酸降低疗法和倍他司汀治疗1个月,而44名受试者仅接受倍他司汀治疗。主观症状通过眩晕障碍量表(DHI)进行评估,在眩晕开始后7天和1个月后再次进行。此外,在21例未接受治疗的患者和20例接受治疗的患者的亚组中,采用静态镇定法研究了在1个月控制时进行的姿势控制。在接受同型半胱氨酸降低治疗的受试者亚组中,DHI总得分的下降幅度更大。此外,与治疗的受试者相比,未治疗的患者的posturographic数据显着增加。我们的数据支持HyHcy在预防近期前庭神经炎后恢复中发挥作用的可能性。 HyHcy的微血管疾病或神经毒性作用被认为是可能的病因。尽管不是结论性的,但我们的数据与未经治疗的HyHcy患者适应性较差的假设并不矛盾。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号